Current through Register 2024 Notice Reg. No. 45, November 8, 2024
Section 10400.3 - Koch Agents for Treatment of Cancer(a) As used in this section, the Koch agents mean those agents described and defined in the report entitled REPORT, FINDINGS AND RECOMMENDATIONS of the CALIFORNIA CANCER ADVISORY COUNCIL to DIRECTOR, CALIFORNIA STATE DEPARTMENT OF PUBLIC HEALTH, 2151 Berkeley Way, Berkeley 4, California, with respect to THE TREATMENT OF CANCER WITH THE KOCH SYNTHETIC ANTITOXINS --(Malonide, Glyoxylide and Parabenzoquinone) dated April 17, 1963, which agents are commonly known as Malonide, Glyoxylide and Parabenzoquinone and are further commonly collectively known as the Koch agents.(b) Except as otherwise provided in Section 1708 of the Health and Safety Code the prescription, administration, sale or other distribution of the three Koch agents, as defined in subsection (a) of this section, or any agents substantially similar thereto, whether singly or in any combination, or in any dosage or guise whatever, in the diagnosis, alleviation, treatment or cure of cancer, or for treatment of any patient who has or who believes that he or she has or who may have cancer is prohibited.(c) No person shall, for the purpose of prescribing, administering, selling or otherwise distributing any or all of the Koch agents, make any representation that the Koch agents, whether singly or in any combination or in any guise whatever, have any value in arresting, alleviating, or curing cancer.Cal. Code Regs. Tit. 17, § 10400.3
1. New section filed 10-3-63; effective thirtieth day thereafter (Register 63, No. 17).
2. Amendment filed 12-17-85; effective thirtieth day thereafter (Register 85, No. 51). Note: Authority cited: Sections 208 and 1704, Health and Safety Code. Reference: Section 1704, Health and Safety Code.
1. New section filed 10-3-63; effective thirtieth day thereafter (Register 63, No. 17).
2. Amendment filed 12-17-85; effective thirtieth day thereafter (Register 85, No. 51).